Amphetamine Stimulant Prodrug denied for failing step therapy by Aetna?

Aetna's specific coverage criteria for amphetamine stimulant prodrug are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies Amphetamine Stimulant Prodrugs Under Step Therapy

Step therapy — sometimes called "fail-first" — requires that you try and document inadequate response to one or more preferred, lower-cost medications before Aetna will cover a higher-tier agent. For stimulant prodrug formulations, Aetna's step-therapy protocol typically requires a trial of one or more conventional amphetamine salt or methylphenidate-class products first. A denial occurs when the plan's records do not reflect a completed, documented step.

## Why This Denial Is Appealable

Step-therapy denials are among the most frequently overturned on appeal because the required prior trial has often occurred but was not documented in a way the insurer's system recognizes — for example, if the prior trial predates your current insurance, was prescribed by a different provider, or was dispensed under a different plan. Additionally, most states and the federal Improving Seniors' Timely Access to Care Act provide step-therapy exception rights when a required step agent is contraindicated, previously failed, or clinically inappropriate. Review the exception criteria in Aetna's policy and your state's step-therapy law.

## Your Federal Appeal Rights

• Step-therapy exception request: Submit this first, before or alongside a formal appeal. Aetna must adjudicate it within the plan's pre-service timeframe (typically 15–30 days; expedited if urgent).
• Internal appeal: If the exception is denied, file a formal appeal within the deadline on the denial notice.
• External review (ACA §2719 / ERISA §503): If the internal appeal is denied, request independent external review within four months. An IRO can evaluate whether applying the step requirement to your clinical circumstances is consistent with accepted practice.
• State step-therapy law: Check whether your state has enacted specific step-therapy patient protections, which may provide additional exception grounds and shorter response timelines.

## Documentation to Gather

1. Prior-treatment history — a chronological list of every stimulant medication tried, with start dates, end dates, doses ranges (do not include specific numbers in the appeal letter itself — reference the chart), and documented clinical outcomes or adverse effects. 2. Prescriber attestation of prior step completion — a signed letter confirming the patient has already completed required prior steps, with chart evidence. 3. Exception grounds documentation — if requesting an exception, chart evidence supporting the applicable ground (contraindication, prior failure, clinical inappropriateness). 4. Pharmacy dispensing records — pull records from prior pharmacies or insurers if the step trial occurred under different coverage.

## Criteria-Mapping Structure

Request Aetna's step-therapy criteria for stimulant medications. Map your evidence step by step:

| Required Step | Evidence of Completion or Exception Ground | |---|---| | Step 1 agent [as listed in Aetna's policy] | [Chart note/pharmacy record date + outcome] | | Step 2 agent (if required) | [Chart note/pharmacy record date + outcome] | | Exception basis (if step not completed) | [Contraindication / prior failure documentation] |

Complete documentation of prior steps is the fastest path to approval. If any step was completed under a prior plan, obtain those pharmacy records and include a prescriber attestation before submitting.